{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:45:13Z","timestamp":1766270713252,"version":"3.48.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal metastasis (PM, or peritoneal carcinomatosis) is often associated with dismal prognosis. The treatment of peritoneal metastasis depends on several factors, including the type of primary cancer, the extent of metastasis and the patient\u2019s overall health condition. Apart from systemic chemotherapy and cytoreductive surgery (CRS), locoregional therapies such as hyperthermic intraperitoneal chemotherapy (HIPEC) or pressurized intraperitoneal aerosol chemotherapy (PIPAC) may improve tumour control. CRS is a complex procedure with high morbidity, performed only in approximately 25% of all eligible patients and the efficiency of other non-surgical therapies is not well known. The place of radiation therapy needs to be defined. A 62-year-old woman was referred for surgery for a few days\u2019 history of large bowel obstruction. A previous abdominopelvic CT showed an obstructive 3-cm mass in the proximal ascending colon, associated with small bowel dilatation. Right hemi-colectomy was performed. Work-up demonstrated on MRI (magnetic resonance imaging) sub-centimetric secondary liver lesions. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (PET\/CT) ruled out other metastatic lesions. After multidisciplinary discussion, peri-operative systemic therapy based on FOLFOX-Bevacizumab was offered and was associated with stable disease for 7\u2009months. Unfortunately, peritoneal progression was detected on PET\/CT imaging. FOLFIRI-Bevacizumab was offered as second line systemic therapy followed by resection of residual masses. The patient was considered in remission for 5\u2009months thereafter. A second isolated peritoneal relapse occurred involving the same 2 distinct sites. Second line chemotherapy was re-challenged. The oligorecurrent PM lesions were considered as non-operable. After multidisciplinary team discussion, stereotactic body radiation therapy (SBRT) was decided. The relapse sites were treated with 48\u2009Gy, delivered in 6 fractions of 8\u2009Gy given every other day. At the 22-month follow-up, the patient showed no signs of relapse on CT imaging and no treatment-related toxicities. Isolated peritoneal oligometastatic metastases are associated with poor prognosis. Cytoreductive surgery remains the historical standard of care treatment but represents a minority of all eligible patients. Our case and few other reports suggest that SBRT is a safe, reasonable, and non-invasive treatment option.<\/jats:p>","DOI":"10.1093\/bjrcr\/uaaf060","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:17:09Z","timestamp":1765207029000},"source":"Crossref","is-referenced-by-count":0,"title":["Peritoneal metastases from colorectal cancer managed by stereotactic body radiation therapy: presentation of a clinical case and review of literature"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-6693","authenticated-orcid":false,"given":"Alexander","family":"Bennassi","sequence":"first","affiliation":[{"name":"Department of Radio-Oncology, Centre de Canc\u00e9rologie de Thiais , Thiais 94320,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislas","family":"Ropert","sequence":"additional","affiliation":[{"name":"Department of Oncology, H\u00f4pital Priv\u00e9 d\u2019Antony , Antony 92160,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5888-8688","authenticated-orcid":false,"given":"Gokoulakrichenane","family":"Loganadane","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institut Curie , Paris 75005,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Dromain","sequence":"additional","affiliation":[{"name":"Department of Radiology, Centre Hospitalier Universitaire Vaudois , Lausanne 1011,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toufik","family":"Bennassi","sequence":"additional","affiliation":[{"name":"Department of Radio-Oncology, Centre de Canc\u00e9rologie de Thiais , Thiais 94320,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2025122017415188100_uaaf060-B1","first-page":"e335","article-title":"Diagnostic nodes of patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy among colorectal cancer patients: a Swiss national multicenter survey","volume":"18","author":"Steffen","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"2025122017415188100_uaaf060-B2","doi-asserted-by":"publisher","first-page":"601739","DOI":"10.3389\/fonc.2020.601739","article-title":"Case report: first in human online adaptive MR guided SBRT of peritoneal carcinomatosis nodules: a new therapeutic approach for the oligo-metastatic patient","volume":"10","author":"Boldrini","year":"2020","journal-title":"Front Oncol"},{"key":"2025122017415188100_uaaf060-B3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0035-1564431","article-title":"Peritoneal carcinomatosis from colon cancer: a systematic review of the data for cytoreduction and intraperitoneal chemotherapy","volume":"28","author":"Nadler","year":"2015","journal-title":"Clin Colon Rectal Surg"},{"key":"2025122017415188100_uaaf060-B4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"2025122017415188100_uaaf060-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13193-018-0856-1","article-title":"Prevention and treatment of peritoneal metastases: a comprehensive review","volume":"10","author":"Sugarbaker","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"2025122017415188100_uaaf060-B6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"2025122017415188100_uaaf060-B7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025122017415188100_uaaf060-B8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.21873\/anticanres.15560","article-title":"Second-look surgery detects low volume recurrent disease following cytoreductive surgery for peritoneal carcinomatosis","volume":"42","author":"Matar","year":"2022","journal-title":"Anticancer Res"},{"key":"2025122017415188100_uaaf060-B9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"2025122017415188100_uaaf060-B10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann. Oncol"},{"key":"2025122017415188100_uaaf060-B11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"2025122017415188100_uaaf060-B12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1556\/650.2015.30183","article-title":"Has\u00fcregi daganat\u00e1tt\u00e9tek stereotaxi\u00e1s sug\u00e1rkezel\u00e9se egy \u00fcl\u00e9sben. Besz\u00e1mol\u00f3 az els\u0151 hazai, kopony\u00e1n k\u00edv\u00fcli sug\u00e1rseb\u00e9szeti beavatkoz\u00e1sr\u00f3l [stereotactic radiosurgery of abdominal cancer metastases. Report on the first successful extracranial radiosurgical intervention in Hungary]","volume":"156","author":"Mangel","year":"2015","journal-title":"Orv Hetil"},{"key":"2025122017415188100_uaaf060-B13","doi-asserted-by":"publisher","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","article-title":"Peritoneal metastases from colorectal cancer: Defining and addressing the challenges","volume":"11","author":"Kranenburg","year":"2021","journal-title":"Front Oncol"},{"key":"2025122017415188100_uaaf060-B14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41467-018-04278-6","article-title":"Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis","volume":"9","author":"Pitroda","year":"2018","journal-title":"Nat Commun"}],"container-title":["BJR|Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjrcr\/advance-article-pdf\/doi\/10.1093\/bjrcr\/uaaf060\/65800584\/uaaf060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjrcr\/article-pdf\/11\/6\/uaaf060\/65800584\/uaaf060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjrcr\/article-pdf\/11\/6\/uaaf060\/65800584\/uaaf060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:41:59Z","timestamp":1766270519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjrcr\/article\/doi\/10.1093\/bjrcr\/uaaf060\/8373886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjrcr\/uaaf060","relation":{},"ISSN":["2055-7159"],"issn-type":[{"type":"electronic","value":"2055-7159"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,11,1]]},"article-number":"uaaf060"}}